HARVARD BIOSCIENCE INC Operating Income Loss

• HARVARD BIOSCIENCE INC showed a decrease of -682.2% in Operating Income Loss from 2024 to 2025.
• This data is from HARVARD BIOSCIENCE INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), HARVARD BIOSCIENCE INC's Operating Income Loss has declined by 703.1%.
• Historical annual values: Fiscal year 2025: -$48.58 million | Fiscal year 2024: -$6.21 million | Fiscal year 2023: $1.89 million | Fiscal year 2022: -$6.93 million | Fiscal year 2021: $2.07 million | Fiscal year 2020: $221.0 thousand | Fiscal year 2019: $377.0 thousand | Fiscal year 2018: $984.0 thousand | Fiscal year 2017: -$635.0 thousand | Fiscal year 2016: -$3.00 million | Fiscal year 2015: -$1.71 million | Fiscal year 2014: $6.62 million | Fiscal year 2013: $1.54 million | Fiscal year 2012: $7.83 million | Fiscal year 2011: $8.41 million | Fiscal year 2010: $10.22 million | Fiscal year 2009: $8.06 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026